Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma

Gordon L. Phillips, B. R. Meisenberg, D. E. Reece, V. R. Adams, A. Z. Badros, J. L. Brunner, R. G. Fenton, J. Filicko, D. L. Grosso, G. A. Hale, D. S. Howard, V. P. Johnson, A. Kniska, K. W. Marshall, B. Mookerjee, R. Nath, A. P. Rapoport, C. Sarkodee-Adoo, N. Takebe, D. H. VesoleJ. L. Wagner, N. Flomenberg

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences